DIETHYL-(3-(4-METHYL-2-OXO-2H-CHROMEN-7-YLOXY)-PROPANAMIDO)-(NAPHTHALEN-2-YL)-METHYLPHOSPHONATE
Compound with spectra: 1 NMR
| SpectraBase Compound ID | 1rU6NtmgNFU |
|---|---|
| InChI | InChI=1S/C28H30NO7P/c1-4-34-37(32,35-5-2)28(22-11-10-20-8-6-7-9-21(20)17-22)29-26(30)14-15-33-23-12-13-24-19(3)16-27(31)36-25(24)18-23/h6-13,16-18,28H,4-5,14-15H2,1-3H3,(H,29,30) |
| InChIKey | JOXCCFHCXHJPGW-UHFFFAOYSA-N |
| Mol Weight | 523.52 g/mol |
| Molecular Formula | C28H30NO7P |
| Exact Mass | 523.175989 g/mol |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
DIETHYL-(3-(4-METHYL-2-OXO-2H-CHROMEN-7-YLOXY)-PROPANAMIDO)-(2-FLUOROPHENYL)-METHYLPHOSPHONATE
DIETHYL-(3-(4-METHYL-2-OXO-2H-CHROMEN-7-YLOXY)-PROPANAMIDO)-(2-BROMOPHENYL)-METHYLPHOSPHONATE
DIETHYL-(3-(4-METHYL-2-OXO-2H-CHROMEN-7-YLOXY)-PROPANAMIDO)-(2-CHLOROPHENYL)-METHYLPHOSPHONATE
1-(4-Methylcoumarinyl-7-oxyacetyl)-3,5-dimethyl-4-(2,4-dimethylphenylazo)pyrazole
N-[2-(3,4-DIHYDROXYPHENYL)-4-OXOTHIAZOLIDIN-3-YL]-2-(4-METHYL-2-OXO-2H-CHROMEN-7-YLOXY)-ACETAMIDE
N-[2-(3-METHOXYPHENYL)-4-OXOTHIAZOLIDIN-3-YL]-2-(4-METHYL-2-OXO-2H-CHROMEN-7-YLOXY)-ACETAMIDE
N-[2-(3-CHLOROPHENYL)-4-OXOTHIAZOLIDIN-3-YL]-2-(4-METHYL-2-OXO-2H-CHROMEN-7-YLOXY)-ACETAMIDE
7-[(4-fluorobenzyl)oxy]-4-(3-nitrophenyl)-2H-chromen-2-one
ethyl 4-isobutyl-2-({[(4-methyl-2-oxo-2H-chromen-7-yl)oxy]acetyl}amino)-3-thiophenecarboxylate
4-TRIFLUOROMETHYLUMBELLIFERYL 2-AMINO-2-DEOXY-ALPHA-D-GLUCOPYRANOSIDE,HYDROCHLORIDE
| Title | Journal or Book | Year |
|---|---|---|
| Novel Coumarin-Containing Aminophosphonatesas Antitumor Agent: Synthesis, Cytotoxicity, DNA-Binding and Apoptosis Evaluation | Molecules | 2015 |
This compound is available in the following databases:
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.